Tradestie Institutional Equity Comparison Engine

TWST vs EDIT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TWST Overall Edge

TWST Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Twist Bioscience Corporation Common Stock (TWST) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TWST trades at N/M Forward P/E with -31.9% operating margin (+23.2% YoY revenue) versus EDIT at N/M Forward P/E and -167.0% operating margin (+37.4% YoY). In options structure, TWST sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against EDIT sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
TWST N/M vs EDIT N/M Fwd P/E
Growth & Margin Winner TWST
Op Margin -31.9% vs -167.0% ยท YoY +23.2% vs +37.4%
Momentum & Technical Winner TWST
1Y +254.0% vs -25.0% ยท 52W Pos 42% vs 11%
Options & Structure Winner TWST
CONSOLIDATION (18th %ile IV) vs BREAKDOWN (38th %ile IV)
TWST NASDAQ
Twist Bioscience Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$105.85
-5.15% 1D
Market Cap $7.6B
1M Return -20.26%
1Y Return +254.01%
Forward P/E N/M
Unified AI Score
51.7 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 68.0 Mom 64.0
EDIT NASDAQ
Editas Medicine, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.91
-12.21% 1D
Market Cap $336.5M
1M Return -18.94%
1Y Return -25.0%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 33.0 Fund 55.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TWST +254.01% EDIT -25.0% Spread: +279.01 pp (TWST Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period TWST Revenue EDIT Revenue TWST Op. Margin EDIT Op. Margin Margin Edge
FY2018 $30M $30M -277.5% -356.1% TWST
FY2019 $50M $20M -200.1% -686.4% TWST
FY2020 $90M $90M -155.5% -148.6% EDIT
FY2021 $130M $30M -115.4% -756.1% TWST
FY2022 $200M $20M -115.3% -1146.3% TWST
FY2023 $250M $80M -88.6% -216.6% TWST
FY2024 $310M $30M -70.6% -777.2% TWST
FY2025 $380M $40M -36.2% -394.9% TWST

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TWST (6) vs EDIT (2)
Institutional Metric TWST EDIT Criterion Row Winner
Market Capitalization Scale $7.6B $336.5M Larger Scale TWST
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +23.2% +37.4% Higher Growth EDIT
Operating Margin (TTM) Profitability -31.9% -167.0% Higher Margin TWST
Net Profit Margin Profitability -31.7% -144.9% Higher Margin TWST
Return on Equity (ROE) Capital Efficiency -29.6% -147.4% Higher ROE TWST
52-Week Range Position Momentum 42% ($23โ€“$220) 11% ($2โ€“$4) Stronger Trend TWST
Beta / 30D Volatility Risk Regime 3.15ฮฒ ยท 127% Vol 2.32ฮฒ ยท 102% Vol Lower Realized Risk EDIT
Unified Institutional Score Composite Signal 51.7 / 100 (HOLD) 48.4 / 100 (HOLD) Higher Composite TWST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TWST vs EDIT Buy Guide
TWST CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live TWST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EDIT BREAKDOWN
146d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live EDIT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TWST nor EDIT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.